Trials / Conditions / Medium-chain Acyl-CoA Dehydrogenase Deficiency

Medium-chain Acyl-CoA Dehydrogenase Deficiency

11 registered clinical trials studyying Medium-chain Acyl-CoA Dehydrogenase Deficiency — 4 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	Study to Evaluate the Use of Triheptanoin in Patients With Medium Chain Acyl-CoA Dehydrogenase Deficiency (MCA NCT07097311	Jerry Vockley, MD, PhD	Phase 2
Suspended	Study of Triheptanoin for the Prevention of Hypoglycemia in Patients With Medium Chain Acyl-CoA Dehydrogenase NCT06067802	Jerry Vockley, MD, PhD	Phase 2
Recruiting	Study of Sodium Phenylbutyrate (ACER-001) for the Treatment of Pediatric and Adults Patients With Medium Chain NCT06773026	Jerry Vockley, MD, PhD	Phase 2
Completed	High Intensity Exercise in Children With MCADD NCT06796530	University Hospital, Ghent	N/A
Recruiting	Metabolic Effects of Medium-Chain Fatty Acids in Patients With Medium-Chain Acyl-CoA Dehydrogenase Deficiency NCT06623032	University of Copenhagen	N/A
Suspended	Study of Sodium Phenylbutyrate (ACER-001) for the Treatment of Patients With Medium Chain Acyl-CoA Dehydrogena NCT06069375	Jerry Vockley, MD, PhD	Phase 2
Unknown	Selective Screening of Children for Hereditary Metabolic Diseases by Tandem Mass Spectrometry in Kazakhstan NCT05910151	West Kazakhstan Medical University	—
Completed	Baby Detect : Genomic Newborn Screening NCT05687474	Centre Hospitalier Universitaire de Liege	—
Enrolling By Invitation	Early Check: Expanded Screening in Newborns NCT03655223	RTI International	—
Completed	Fatty Acid Oxidation Defects and Insulin Sensitivity NCT02517307	Oregon Health and Science University	N/A
Unknown	Fat and Sugar Metabolism During Exercise in Patients With Metabolic Myopathy NCT02635269	Rigshospitalet, Denmark	N/A